Table 1 Baseline characteristics
From: Effects of smoking cessation on endothelial function as assessed by flow-mediated total dilation
|  | Overall (n = 118) | Females (n = 32) | Males (n = 86) | p value |
|---|---|---|---|---|
Age, years | 59 ± 11 | 59 ± 12 | 59 ± 11 | 0.868 |
BMI, kg/m² | 23.7 ± 3.7 | 22.1 ± 2.8 | 24.3 ± 3.8 | 0.003** |
Brinkman index | 815 ± 400 | 700 ± 308 | 858 ± 422 | 0.055 |
Cigarettes per day | 23 ± 10 | 21 ± 6 | 24 ± 10 | 0.088 |
CO concentration, ppm | 15.4 ± 10.3 | 14.1 ± 10.6 | 15.9 ± 10.3 | 0.414 |
Hypertension | 37.3% (n = 44) | 31.3% (n = 10) | 39.5% (n = 34) | 0.522 |
SBP, mmHg | 119.0 ± 17.8 | 117.5 ± 19.9 | 119.6 ± 17.0 | 0.558 |
DBP, mmHg | 75.9 ± 10.1 | 74.3 ± 11.1 | 76.5 ± 9.7 | 0.294 |
HR, beats/min | 66.0 ± 11.8 | 66.6 ± 10.8 | 65.8 ± 12.2 | 0.769 |
Diabetes mellitus | 23.7% (n = 28) | 28.1% (n = 9) | 22.1% (n = 19) | 0.659 |
HbA1c, % | 6.0 ± 0.9 | 6.0 ± 0.8 | 6.0 ± 0.9 | 0.870 |
Fasting glucose, mg/dl | 100.7 ± 20.5 | 99.2 ± 18.7 | 101.2 ± 21.3 | 0.628 |
Dyslipidemia | 68.6% (n = 81) | 68.8% (n = 22) | 68.6% (n = 59) | 1.000 |
HDL-C, mg/dl | 50.4 ± 14.5 | 60.5 ± 15.7 | 46.6 ± 12.1 | < 0.001** |
LDL-C, mg/dl | 114.6 ± 33.0 | 123.7 ± 33.3 | 111.2 ± 32.4 | 0.067 |
Triglycerides, mg/dl | 151.4 ± 99.2 | 127.6 ± 70.6 | 160.2 ± 106.9 | 0.119 |
eGFR, ml/min/1.73 m² | 75.9 ± 20.0 | 74.7 ± 26.4 | 76.4 ± 17.1 | 0.694 |
Medication | Â | Â | Â | Â |
Antihypertensive | 30.2% (n = 35) | 28.1% (n = 9) | 31.0% (n = 26) | 0.767 |
Oral hypoglycemic | 15.7% (n = 18) | 21.9% (n = 7) | 13.3% (n = 11) | 0.254 |
Lipid lowering | 24.3% (n = 28) | 31.3% (n = 10) | 21.7% (n = 18) | 0.284 |
Dbase, mm | 4.11 ± 0.67 | 3.45 ± 0.54 | 4.35 ± 0.54 | < 0.001** |
L-FMC | 33.9% (n = 40) | 21.9% (n = 7) | 38.4% (n = 33) | 0.143 |
%L-FMC, % | -1.16 ± 1.99 | -1.08 ± 2.37 | -1.19 ± 1.85 | 0.788 |
%FMD, % | 4.05 ± 2.13 | 3.95 ± 2.26 | 4.09 ± 2.09 | 0.759 |
%FMTD, % | 5.21 ± 2.54 | 5.03 ± 2.54 | 5.28 ± 2.55 | 0.641 |
baIMT, mm | 0.31 ± 0.07 | 0.28 ± 0.06 | 0.32 ± 0.08 | 0.029 * |